ResearcherChinese PLA General HospitalActive in the last 2 years

Meijuan Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9209-3184; OpenAlex author ID A5088089023. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Establishing Pancreatic Cancer Organoids from EUS-Guided Fine-Needle Biopsy Specimens. Co-author DOI 10.3390/cancers17040692 ↗
Polydopamine-Based Resveratrol-Hyaluronidase Nanomedicine Inhibited Pancreatic Cancer Cell Invasive Phenotype in Hyaluronic Acid Enrichment Tumor Sphere Model. Co-author DOI 10.1021/acsptsci.3c00304 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lianyong Li · 1 shared paper, 2025 · strength 0.27
- Paper Establishing Pancreatic Cancer Organoids from EUS-Guided Fine-Needle Biopsy Specimens. DOI 10.3390/cancers17040692 ↗
Chao Gao · 1 shared paper, 2025 · strength 0.27
- Paper Establishing Pancreatic Cancer Organoids from EUS-Guided Fine-Needle Biopsy Specimens. DOI 10.3390/cancers17040692 ↗
Shuo Yu · 1 shared paper, 2024 · strength 0.20
- Paper Polydopamine-Based Resveratrol-Hyaluronidase Nanomedicine Inhibited Pancreatic Cancer Cell Invasive Phenotype in Hyalur… DOI 10.1021/acsptsci.3c00304 ↗
Tinghua Hu Hu · 1 shared paper, 2024 · strength 0.20
- Paper Polydopamine-Based Resveratrol-Hyaluronidase Nanomedicine Inhibited Pancreatic Cancer Cell Invasive Phenotype in Hyalur… DOI 10.1021/acsptsci.3c00304 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.